Vaccination and rheumatoid diseases: a shared decision making process - Safety and effectiveness of COVID-19 vaccines

Global Rheumatology

Estefania Fajardo¹  Carlo V Caballero-Uribe² 

[1] Global Rheumatology;Universidad del Norte;

关键词: vaccination;    covid-19;    pandemic;    rheumatic diseases;    rheumatology;    vaccine;   

DOI  :  https://doi.org/10.46856/grp.26.e076

来源: DOAJ

【 摘 要 】

Vaccination against COVID-19 is currently the most important scientific response to the global threat that the pandemic has represented. This two-part exclusive article about vaccination and rheumatic diseases appears as a response to the need of keeping PANLAR* members, Board of Directors and Global Rheumatology community up to date with the latest developments related to COVID-19. This first issue will address relevant aspects of vaccine safety and efficacy. The second issue, appearing next week, will present special considerations about COVID-19 cases with pre-existing autoimmune rheumatic diseases. We will be always keeping in mind that patients and physicians should be properly informed in their shared decision making processes.

【 授权许可】

Unknown